A phase 2 study of zanubrutinib in previously treated B‐cell malignancies intolerant to ibrutinib and/or acalabrutinib: Preliminary results for patients with CLL/SLL

Saved in:

Bibliographic Details
Published in	Hematological oncology Vol. 41; no. S2; pp. 469 - 471
Main Authors	Shadman, M., Burke, J. M., Zafar, S. F., Misleh, J., Rao, S. S., Farber, C. M., Cohen, A., Crescenzo, R., By, K., Flinn, I. W., Sharman, J. P.
Format	Journal Article
Language	English
Published	Chichester Wiley Subscription Services, Inc 01.06.2023
Subjects	Chronic lymphocytic leukemia Malignancy
Online Access	Get full text

Loading…

More Information
ISSN:	0278-0232 1099-1069
DOI:	10.1002/hon.3164_345